EPROXINDINE HYDROCHLORIDE IN VENTRICULAR PREMATURE COMPLEXES

盐酸依普罗西定治疗室性早搏

• 批准号: 3923707
• 负责人: STEPHEN F SCHAAL
• 金额: --
• 依托单位: OHIO STATE UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3923707
• 关键词: cardiovascular agents; heart disorder chemotherapy; human subject; human therapy evaluation; intravenous administration; premature ventricular contractions

The objective of this study is to examine the effects of eproxindine hydrochloride on VPC suppression when given as a single IV 20 minute infusion of 50-100 mg to patients with chronic stable ventricular premature complexes and to examine the safety and tolerance of eproxindine hydrochloride when given intravenously to patients.

本研究的目的是检验 单次给药时盐酸依维林定对VPC抑制的影响 慢性稳定型患者静脉输注50-100 mg，20分钟 室性期前综合征并检查其安全性和 盐酸依维林定静脉给药时的耐受性 患者